🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to characterize the systemic pharmacokinet...
Status
Completed
Location
Medical Facility, Salt Lake City
Start Date
2024-11-20
Trial ID
NCT06727136
Treatments Being Tested
To assess the effect of a single dose of aluminum hydroxide/magnesium hydro...
Status
Completed
Location
Medical Facility
Start Date
2020-07-01
Trial ID
NCT04368585
This is a randomized, double-blind (with respect to Tebipenem pivoxil hydro...
Status
Completed
Location
Celerion
Start Date
2020-01-19
Trial ID
NCT04238195
The primary purpose of the study is to compare the concentrations of tebipe...
Status
Completed
Location
BioPharma Services
Start Date
2023-05-04
Trial ID
NCT05856747
Treatments Being Tested
The primary purpose of this study is to assess the efficacy of oral TBP-PI-...
Status
Completed
Location
Medical facility
Start Date
2023-12-21
Trial ID
NCT06059846
Treatments Being Tested
This study will determine the tissue penetration of a broad-spectrum orally...
Status
Completed
Location
Hartford Hospital
Start Date
2021-07-01
Trial ID
NCT04919954
Treatments Being Tested
This is a double-blind, placebo-controlled, ascending dose, multi-cohort tr...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2017-10-20
Trial ID
NCT03395249
Treatments Being Tested
The key purpose of this study is to evaluate the efficacy, safety and pharm...
Status
Completed
Location
Medical Facility
Start Date
2019-06-03
Trial ID
NCT03788967
Treatments Being Tested
The purpose of this study is to measure the amount of the antibiotic, tebip...
Status
Completed
Location
Hartford Hospital
Start Date
2022-04-01
Trial ID
NCT05296382
Treatments Being Tested
To evaluate the intrapulmonary pharmacokinetics (PK), including ELF and AM ...
Status
Completed
Location
Pulmonary Associates
Start Date
2020-12-07
Trial ID
NCT04710407
Treatments Being Tested